Materials and Methods: A total of 325 patients who underwent ureteroscopy at our clinic between January 2019 and May 2024 were included in the study. Patients who had symptomatic infections, malignancy or hematological diseases were excluded from the study. Based on preoperative urine culture results, patients were divided into two groups: Group 1 (negative urine culture) and Group 2 (recurrent positive or contaminated urine cultures). Demographic, clinical, radiological and surgical data were retrospectively collected and statistically analyzed.
Results: Among 325 patients, Group 1 consisted of 268 patients (82.5%), while Group 2 consisted of 57 patients (17.5%). The median age of patients in Group 2 was significantly higher (p = 0.021). The proportion of female patients was higher in Group 2 (52.6%) compared to Group 1 (25.4%) (p < 0.001). Diabetes mellitus, hypertension and chronic kidney disease were significantly more prevalent in Group 2 (p < 0.05). The frequency of postoperative fever and duration of hospital stay were significantly higher in Group 2 (p < 0.001). No cases of urosepsis or more severe than Clavien-Dindo grade 2 complications were observed in any patient.
Conclusion: Our study showed that ureteroscopy may be performed safely under antibiotic treatment in patients with persistently positive urine cultures without causing serious complications. Thus, delaying surgery solely for urine sterilization may not be necessary under appropriate antibiotic treatment.
Surgical treatment options include ureteroscopy (URS), shock wave lithotripsy (SWL) and percutaneous nephrolithotomy (PCNL) for most of the patients. It is known that among these treatment options, URS has lower complication rates compared to PCNL and higher stone-free rates compared to SWL [5]. With technological advancements and the development of endoscopic devices in more practical forms, ureteroscopy has gained increasing application even in >2 cm diameter stones. Due to its high treatment success and low morbidity, it is becoming an increasingly preferred treatment option for the management of ureteral and kidney stones [6].
Although a substantial proportion of complications following URS are minor and do not require further intervention, the overall complication rate can reach up to 25% [5,7]. Among these, infectious complications such as postoperative fever, urinary tract infections, systemic inflammatory response syndrome (SIRS), and urosepsis are particularly concerning [7-10]. Preoperative bacteriuria is a known risk factor for such complications, especially in patients with additional risk factors including female gender, chronic diseases, higher American Society of Anesthesiologists (ASA) physical status classification system score, hydronephrosis, or infectious stones [11,12]. While prophylactic antibiotics and careful perioperative management can help reduce these risks [13] a positive preoperative urine culture remains a significant predictor of postoperative infection and should be managed accordingly [14]. However, in patients with urinary tract stone disease, achieving sterile urine cultures may not always be possible due to persistent or recurrent bacteriuria and contamination [15]. The belief that persistent urine culture positivity increases the risk of surgical complications may heighten anxiety for both the patient and the urologist. This concern often leads to repeated antibiotic use, which contributes to bacterial resistance and may increase patient's morbidity [16]. Additionally, delaying surgery in pursuit of urine sterilization prolongs hospitalization, raises healthcare costs, and may result in irreversible renal damage due to ongoing obstruction [17]. Despite these challenges, there is currently no clear consensus on whether URS should be delayed until urine cultures are sterile or whether it can be performed safely under targeted antibiotic therapy [18].
In this single-center, retrospective study, we hypothesized that URS can be performed safely in patients with persistent positive or contaminated urine cultures, provided that appropriate antibiotic treatment is administered. Therefore, we aimed to compare the surgical outcomes of patients with sterile preoperative urine cultures and those with persistent non-sterile cultures.
Figure 1. Flow chart of the patient's selection
A positive urine culture was defined as the isolation of a single uropathogenic organism at a concentration of ≥10⁵ colony-forming units per milliliter (CFU/mL). Contaminated cultures were characterized by mixed bacterial growth or the presence of non-uropathogenic organisms. Due to their similar clinical impact in terms of delaying treatment, both groups were pooled together and analyzed as a single cohort (Group 2).
Demographic, laboratory, imaging, and surgical data were retrieved from the hospital database and reviewed retrospectively. For the assessment of complications, the Modified Clavien classification system (MCCS), previously introduced by Mandal et al. for URS, was used [9]. Stone-free status was evaluated 6-8 weeks after surgery using ultrasound, X-ray, and/ or computerized tomography (CT). In the late follow-up period, if the patient had no additional complaints, monitoring was conducted using ultrasound only. The groups were compared statistically in terms of postoperative complications, hospital stay, and stone-free rates.
Surgical Technique
Ureteroscopy was performed using semirigid ureteroscopes
(8 Fr and 9.5 Fr, Karl Storz®, Tuttlingen, Germany) and singleuse
flexible ureteroscopes (9 Fr, Redpine®, Guangzhou). Flexible
ureteroscopy procedure was performed using an aspirated
access sheath (Clear-Petra®). Lithotripsy was performed using a holmium: YAG laser system (272 μm). None of the patients
exhibited purulent urine in the collecting system during the
procedure. At the end of the procedure, some patients did not
require ureteral catheterization, while in those who did, either a 5
Fr ureteral catheter or a 4.8 Fr double J ureteral stent was placed.
Statistical Analysis
The continuous variables were presented as medians, along
with counts and percentages when applicable. Data analyzed
using statistical software (IBM Corp. Released 2019. IBM SPSS
Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp).
Mann Whitney U test was used in cross-group comparisons
of variables that did not show normal distribution. Pearson
Chi-Square test and Fisher's Exact test were used to compare
qualitative data. Statistical significance was set at p<0.05 level
in outcome analysis.
Table 1. Demographic and clinical characteristics of the patients
Among 325 patients, Group 1 consisted of 268 patients (82.5%), while Group 2 consisted of 57 patients (17.5%). There was no statistically significant difference between the two groups regarding surgical procedure and duration, stone location and size, preoperative hydronephrosis status, systemic inflammatory response indices (SIRI-SII), type of catheterization, and postoperative pain (p > 0.05). The median age of patients in group 2 was significantly higher (p = 0.021). The proportion of female patients was 52.6% in group 2, whereas it was 25.4% in group 1, indicating that nearly half of the patients with positive urine cultures were female. In contrast, the proportion of female patients was significantly lower in the culture-negative group (p < 0.001). Additionally, the frequency of postoperative fever and length of hospital stay were significantly higher in group 2 (p < 0.001). Comparison of the groups is shown in Table 2.
Table 2. Comparison of groups in terms of clinical and surgical characteristics
Diabetes mellitus, hypertension, and chronic kidney disease were significantly more prevalent in group 2 (p < 0.05). In contrast, no statistically significant difference was observed between the groups regarding coronary artery disease, smoking, and alcohol consumption (p > 0.05). Relevant data are shown in Table 3.
Despite significant technological advances in endoscopic stone surgery, complications associated with these procedures can still occur in clinical practice. Complication rates in the literature vary considerably, ranging from conditions that do not require additional intervention, such as ureteral stent discomfort or ureteral mucosal injury, to conditions with high mortality rates, such as urosepsis and even ureteral avulsion [21]. Early postoperative complications following URS or Retrograde intrarenal surgery such as fever, urinary tract infection, and progression to urosepsis, are frequently reported as major complications in the literature [21,22]. Fever and urinary tract infection after URS occur in 0.2% to 15% of cases [7-9]. Rarely, these conditions may progress to pyelonephritis and urosepsis due to inadequate treatment or underlying comorbidities. In a multicenter prospective study published in 2015 by Daels et al., which included more than 10,000 patients and investigated the risk factors for URS complications, it was found that the prevalence of diabetes mellitus and hypertension increased with age and that the probability of postoperative complications was higher in patients with diabetes, cardiovascular disease, obesity or receiving anticoagulant therapy [23]. In our study, hypertension, diabetes mellitus and chronic kidney disease were statistically significantly more common in group 2, and therefore the hospital stay in this patient group was longer.
In a retrospective study by Uchida et al. involving 469 patients who underwent URS , risk factors for the development of postoperative systemic SIRS were evaluated [24]. A positive urine culture was detected in 12.4% of the patients before the procedure and the procedure was performed during antibiotic treatment. However, SIRS was significantly more common after URS in patients with a positive urine culture before surgery. The article emphasizes that SIRS increases the length of hospital stay and the economic and social burden for both the patient and the healthcare system, while it is also stated that no fatal SIRS cases developed. In our study, a positive urine culture was detected in 17.5% of the patients before surgery. Although the length of hospital stays and postoperative fever rates were higher in these patients compared to patients with sterile cultures, SIRS or urosepsis was not observed in any patient. In the aforementioned study, 21.3% of the patients had a history of obstructive pyelonephritis and approximately 5% of the patients underwent bilateral stone surgery. We believe that this situation has an impact on the SIRS result. In addition, none of the patients in our study had a history of obstructive pyelonephritis and we would like to emphasize that the period from diagnosis to treatment should not be prolonged under appropriate conditions. In addition, although the female gender was found to be statistically significant in terms of SIRS development in the study in question, no difference was observed between the two genders in terms of postoperative fever and hospital stay in our study. In our study, the median age and female gender ratio were found to be statistically significantly higher in Group 2 and therefore the hospital stay was found to be significantly longer in this group.
Rao et al. [25] identified preoperative bacteriuria as a significant risk factor for urosepsis, while Matlaga et al. [26] suggested that urinary tract infection could be considered a contraindication for URS due to the potential risk of urosepsis. However, a positive urine culture alone may not be indicative in patients with stones who lack clinical symptoms. Consequently, one study proposed that it is more informative to correlate urine microscopy with culture and symptoms [27]. In our study, urine microscopy data were not assessed; however, none of the patients with positive urine culture results or contamination exhibited symptomatic urinary tract infections.
In a retrospective study of 170 patients by Sahin et al., patients who underwent URS after receiving appropriate antibiotics and had preoperative positive urine cultures were compared with patients with negative urine cultures [28]. This study particularly emphasized that there was no statistically significant difference in infectious complication rates (such as fever and septic findings), length of hospital stays or readmission rates between patients who had positive urine cultures and who underwent URS without a control urine culture after a maximum of 10 days of antibiotic therapy and patients with negative urine cultures. Similarly, in our study, patients with positive urine cultures received appropriate treatments and were operated on under antibiotic treatment. However, in this study, it is understood that the positive cultures were not repeated but the first culture results. In our study, the number of patients was approximately twice the number of patients in the aforementioned study, and patients with contaminated or repeated positive urine cultures were evaluated; the length of hospital stay and postoperative fever were found to be significantly higher in this group. The higher median age of patients in group 2 and the presence of additional diseases may have also been effective in this situation. There is no statistically significant difference in terms of age and comorbidities between the two groups compared in the relevant study.
Delay in the treatment of urinary stone disease, especially in patients with positive urine culture, can lead to serious consequences on renal function. Studies have shown that persistent obstruction due to stones increases intrarenal pressure, leading to ischemic damage, nephron loss, and ultimately chronic kidney disease [29]. When infection is present, the risk of pyonephrosis and sepsis further worsens renal damage, requiring urgent intervention [30]. Long-term untreated obstruction can lead to irreversible renal function deterioration, emphasizing the importance of early diagnosis and appropriate treatment. Therefore, timely drainage and definitive stone treatment in infected cases are critical to preserve renal function and prevent long-term complications [29].
The present study demonstrated that the patients who received appropriate and sufficient antimicrobial treatment, i.e., those who underwent surgery with antibiotic coverage, preoperative positive urine culture was associated with lowergrade complications such as fever and extended hospital stay, but did not lead to severe complications like urosepsis. We can conclude that repeated positive urine cultures, both from the patient and the physician's perspective, pose a high risk in terms of surgery and may increase anxiety for both parties. Thus, patients with no urinary infection findings but resistant urine culture growth can be operated on without delay after being informed in detail. Keeping the time from diagnosis to surgical treatment short will also minimize the risk of renal function loss, which can reduce both patient morbidity and surgeon anxiety.
The inclusion of patients with recurrent positive or contaminated urine cultures adds both novelty and real-world relevance to our study, highlighting that surgical intervention can be safely performed under appropriate antibiotic coverage in this challenging patient population. Although the retrospective design of the study represents a limitation, the use of a prospectively maintained institutional database enhances data quality and integrity. Furthermore, the relatively large sample size supports the external validity and generalizability of our findings. Despite its strengths, this study has several limitations that should be acknowledged. First, urine microscopy data were not available, limiting the ability to correlate culture results with microscopic evidence of infection. Second, the distinction between contaminated and truly positive cultures was based on standard microbiology reporting without a universally accepted or validated definition, which may introduce classification bias. Third, the study was conducted at a single center with small sample size, which may limit the generalizability of the findings to other settings with different patient populations or surgical practices. Lastly, variations in surgeon experience and intraoperative decision-making were not controlled for, which could have influenced complication rates and clinical outcomes.
Ethics Committee Approval: Ethical approval for this study was obtained from Istanbul Training and Research Hospital Local Ethics Committee (Approval number: 2024/128)
Informed Consent: An informed consent was obtained from all the patients.
Publication: The results of the study were not published in full or in part in form of abstracts.
Peer-review: Externally peer-reviewed.
Authorship Contributions: Any contribution was not made by any individual not listed as an author. Concept – M.H.E.A., Y.Ş.; Design – M.H.E.A., Y.Ş.; Supervision– H.A.A., M.H.E.A., Y.Ş., U.Y.; Resources – H.A.A., Y.Ş.; Materials – H.A.A., M.H.E.A., Y.Ş.; Data Collection and/or Processing – H.A.A., M.H.E.A., Y.Ş.; Analysis and/or Interpretation – H.A.A., M.H.E.A., Y.Ş., U.Y.; Literature Search – M.H.E.A., Y.Ş.; Writing Manuscript – H.A.A., M.H.E.A., Y.Ş.; Critical Review – H.A.A., M.H.E.A., Y.Ş., U.Y.
Conflict of Interest: The authors declare that they have no conflicts of interest.
Financial Disclosure: The authors declare that this study received no financial support.
1) Curhan GC. Epidemiology of stone disease. Urol Clin
North Am 2007;34(3):287-93.
https://doi.org/10.1016/j.ucl.2007.04.003
2) Lotan Y. Economics and cost of care of stone disease. Adv
Chronic Kidney Dis 2009;16(1):5-10.
https://doi.org/10.1053/j.ackd.2008.10.002
3) Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati
J, Lotan Y. Epidemiology of stone disease across the
world. World J Urol 2017;35(9):1301-20.
https://doi.org/10.1007/s00345-017-2008-6
4) Zhe M, Hang Z. Nephrolithiasis as a risk factor of chronic
kidney disease: a meta-analysis of cohort studies with
4,770,691 participants. Urolithiasis 2017;45(5):441-8.
https://doi.org/10.1007/s00240-016-0938-x
5) Geavlete P, Georgescu D, Niţă G, Mirciulescu V, Cauni V.
Complications of 2735 retrograde semirigid ureteroscopy
procedures: a single-center experience. J Endourol
2006;20(3):179-85.
https://doi.org/10.1089/end.2006.20.179
6) Assimos D, Krambeck A, Miller NL, Monga M, Murad
MH, Nelson CP, et al. Surgical management of stones:
American Urological Association/Endourological Society
Guideline, PART I. J Urol 2016;196(4):1153-60.
https://doi.org/10.1016/j.juro.2016.05.090
7) Perez Castro E, Osther PJ, Jinga V, Razvi H, Stravodimos
KG, Parikh K, et al. Differences in ureteroscopic stone
treatment and outcomes for distal, mid-, proximal, or
multiple ureteral locations: the clinical research office of
the endourological society ureteroscopy global study. Eur
Urol 2014;66(1):102-9.
https://doi.org/10.1016/j.eururo.2014.01.011
8) de la Rosette J, Denstedt J, Geavlete P, Keeley F,
Matsuda T, Pearle M, et al. The clinical research office
of the endourological society ureteroscopy global study:
indications, complications, and outcomes in 11,885
patients. J Endourol 2014;28(2):131-9.
https://doi.org/10.1089/end.2013.0436
9) Mandal S, Goel A, Singh MK, Kathpalia R, Nagathan DS,
Sankhwar SN, et al. Clavien classification of semirigid
ureteroscopy complications: a prospective study. Urology
2012;80(5):995-1001.
https://doi.org/10.1016/j.urology.2012.05.047
10) Somani BK, Giusti G, Sun Y, Osther PJ, Frank M, De Sio
M, et al. Complications associated with ureterorenoscopy
(URS) related to treatment of urolithiasis: the Clinical
Research Office of Endourological Society URS Global
study. World J Urol 2017;35(4):675-81.
https://doi.org/10.1007/s00345-016-1909-0
11) Hsieh CH, Yang SS, Lin CD, Chang SJ. Are prophylactic
antibiotics necessary in patients with preoperative sterile
urine undergoing ureterorenoscopic lithotripsy? BJU Int
2014;113(2):275-80.
https://doi.org/10.1111/bju.12502
12) Sohn DW, Kim SW, Hong CG, Yoon BI, Ha US, Cho YH.
Risk factors of infectious complication after ureteroscopic
procedures of the upper urinary tract. J Infect Chemother
2013;19(6):1102-8.
https://doi.org/10.1007/s10156-013-0632-7
13) Chugh S, Pietropaolo A, Montanari E, Sarica K, Somani
BK. Predictors of urinary ınfections and urosepsis after
ureteroscopy for stone disease: a systematic review from
EAU Section of Urolithiasis (EULIS). Curr Urol Rep
2020;21(4):16.
https://doi.org/10.1007/s11934-020-0969-2
14) Gonen M, Turan H, Ozturk B, Ozkardes H. Factors
affecting fever following percutaneous nephrolithotomy: a
prospective clinical study. J Endourol 2008;22(9):2135-8.
https://doi.org/10.1089/end.2008.0139
15) Ripa F, Pietropaolo A, Montanari E, Hameed BMZ,
Gauhar V, Somani BK. Association of kidney stones and
recurrent utıs: the chicken and egg situation. a systematic
review of literature. Curr Urol Rep 2022;23(9):165-74.
https://doi.org/10.1007/s11934-022-01103-y
16) Ventola CL. The antibiotic resistance crisis: part 1: causes
and threats. P T 2015;40(4):277-83.
https://pubmed.ncbi.nlm.nih.gov/25859123/
17) Proietti S, Gaboardi F, Giusti G. Endourological stone
management in the era of the COVID-19. Eur Urol
2020;78(2):131-3.
https://doi.org/10.1016/j.eururo.2020.03.042
18) Ripa F, Massella V, Ong A, Mani Sinha M, Pietropaolo
A, Somani BK. Role of ureteroscopy (URS) and stone
treatment in patients with recurrent UTIs: outcomes over a
10-year period. J Clin Med 2023;12(10):3591.
https://doi.org/10.3390/jcm12103591
19) Dindo D, Demartines N, Clavien PA. Classification of
surgical complications: a new proposal with evaluation in
a cohort of 6336 patients and results of a survey. Ann Surg
2004;240(2):205-13.
https://doi.org/10.1097/01.sla.0000133083.54934.ae
20) Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti
A, Ticinesi A, et al. The risk of chronic kidney disease
associated with urolithiasis and its urological treatments:
a review. J Urol 2017;198(2):268-73.
https://doi.org/10.1016/j.juro.2016.12.135
21) De Coninck V, Keller EX, Somani B, Giusti G, Proietti
S, Rodriguez-Socarras M, et al. Complications of
ureteroscopy: a complete overview. World J Urol
2020;38(9):2147-66.
https://doi.org/10.1007/s00345-019-03012-1
22) D'Addessi A, Bassi P. Ureterorenoscopy: avoiding and
managing the complications. Urol Int 2011;87(3):251-9.
https://doi.org/10.1159/000329286
23) Daels FP, Gaizauskas A, Rioja J, Varshney AK, Erkan E,
Ozgok Y, et al. Age-related prevalence of diabetes mellitus,
cardiovascular disease and anticoagulation therapy use in
a urolithiasis population and their effect on outcomes: the
Clinical Research Office of the Endourological Society
Ureteroscopy Global Study. World J Urol 2015;33(6):859-64.
https://doi.org/10.1007/s00345-014-1382-6
24) Uchida Y, Takazawa R, Kitayama S, Tsujii T. Predictive
risk factors for systemic inflammatory response syndrome
following ureteroscopic laser lithotripsy. Urolithiasis
2018;46(4):375-81.
https://doi.org/10.1007/s00240-017-1000-3
25) Rao PN, Dube DA, Weightman NC, Oppenheim BA,
Morris J. Prediction of septicemia following endourological
manipulation for stones in the upper urinary tract. J Urol
1991;146(4):955-60.
https://doi.org/10.1016/s0022-5347(17)37974-0
26) Matlaga BR, Lingeman JE. Surgical management of stones:
new technology. Adv Chronic Kidney Dis 2009;16(1):60-4.
https://doi.org/10.1053/j.ackd.2008.10.008
27) Wang A, Nizran P, Malone MA, Riley T. Urinary tract
infections. Prim care 2013;40(3):687-706.
https://doi.org/10.1016/j.pop.2013.06.005
28) Sahin C, Sobay R, Asik A, Sahinler EB, Yildirim S, Kul
K, et al. Confirmation of negative urine culture status after
appropriate antibiotic treatment prior to endourological
stone procedures: Is it really necessary? Urolithiasis
2024;52(1):30.
https://doi.org/10.1007/s00240-023-01524-5